Showing results (631-640 of 1,091) with videos related to

Sort By:
Pageof 110
Cytometry. Part B, Clinical Cytometry|August 22, 2023
Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detectionSa A Wang, Jeffrey L Jorgensen, Shimin Hu, et al.
Molecular Cancer|November 12, 2010
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cellsWeina Chen, Elias Drakos, Ioannis Grammatikakis, et al.
Cancer|July 29, 2009
Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosisSergej Konoplev, Xuelin Huang, Harry A Drabkin, et al.
Journal of Hematopathology|August 12, 2009
Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemiaDongjiu Ye, Guillermo Garcia-Manero, Hagop M Kantarjian, et al.
The Journal of Molecular Diagnostics : JMD|December 27, 2016
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid TumorsRajyalakshmi Luthra, Keyur P Patel, Mark J Routbort, et al.
The American Journal of Surgical Pathology|December 13, 2012
Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer CenterShaoying Li, Xiaoli Feng, Ting Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of diseaseJesse M Jaso, C Cameron Yin, Victoria W Lu, et al.
American Journal of Hematology|March 3, 2017
Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasmAlireza Salem, Sanam Loghavi, Guilin Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphomaJoseph D Khoury, L Jeffrey Medeiros, George Z Rassidakis, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2017
Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphismsJun Tang, Stacey A Jones, Jerry L Jeffrey, et al.
Pageof 110